US Patent Issued to TAIWAN LIPOSOME, TLC BIOPHARMACEUTICALS on April 29 for "Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,524, issued on April 29, was assigned to TAIWAN LIPOSOME Co. LTD. (Taipei, Taiwan) and TLC BIOPHARMACEUTICALS INC. (South San Francisco, Calif.).

"Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof" was invented by Keelung Hong (South San Francisco, Calif.), Jonathan Fang (South San Francisco, Calif.), Hao-Wen Kao (South San Francisco, Calif.), Yi-Yu Lin (South San Francisco, Calif.) and Walter Gwathney (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising at least one liposome and an antipsychotic drug with a hi...